23.10.2025

CREGS study marks a major milestone in stroke research

Large Cerebrolysin® study demonstrates significant functional and cognitive benefits
Read more
03.10.2025

Follow-up on AMN Congress – Advancing Neurotrauma Care

July 4–5, 2025 — Bangkok, Thailand
Read more
24.09.2025

WSC 2025 - Visit us!

World Stroke Congress 2025 | October 22–24 | Barcelona
Read more
16.09.2025

Follow-up on NTSC Extended – 1st Thailand Edition

Bangkok, Thailand – July 3, 2025
Read more
1 2 3 … 37
Go to Archive

Congresses

11th European Stroke Organisation Conference

Helsinki, Finland
21 - 23 May 2025
GO TO EVENT

17th World Stroke Congress

Barcelona, Spain
22 - 25 October 2025
GO TO EVENT

Notice to U.S. Visitors

Please be advised that Cerebrolysin is not registered with the U.S. Food and Drug Administration (FDA) and is not approved for sale or distribution in the United States.

Cerebrolysin is a prescription medication for use under the supervision of an authorized health care professional. For any medical inquiries, please consult with a healthcare professional.